Ophthalmology

Top Story

BLOG: Measuring dry eye symptoms — SANDE doesn’t measure up

August 4, 2015

The most important measurement in treating dry eye is patient symptoms. Remember? You have to know what’s bugging them so you know what to fix. It’s helpful to know how much it’s bugging them so you know how well you are doing with your treatment. Whenever I lecture on dry eye or consult with a practice on starting up a dry eye service (shameless plug: I’m available!), I always ask the folks I’m addressing to tell me what kinds of complaints they hear from dry eye patients. My audience always misses the No. 1 and No. 2 complaints. No. 1 is — wait for it — "my eyes are dry." Duh. No. 2 as we learned from the PROOF study is some variation on "my vision is blurry."

It’s important to be on the lookout for as many symptom tip-offs as possible, either in the patient history or on your dry eye questionnaire. For sure, you need to at least ask about dryness and blurry vision. In July’s Ophthalmology, Amparo and colleagues propose the use of the SANDE test as an alternative to the OSDI. They are especially enthusiastic about how quick and intuitive the SANDE test was. For those of you not familiar, SANDE asks only how often your eyes feel dry or irritated and how severe are your symptoms.

FDA News

Bausch + Lomb receives 510(k) clearance for modified Victus interface kit

August 3, 2015
Bausch + Lomb has received 510(k) clearance from the FDA for an enhanced patient interface kit for the Victus femtosecond laser platform, according to a company…
Breaking News

Omeros receives marketing authorization for Omidria in European Union

August 3, 2015
The European Commission has granted marketing authorization for Omidria for use in cataract surgery and lens replacement procedures in the European Union, Omeros…
Shire acquires Foresight Biotherapeutics for $300 million Business News

Shire acquires Foresight Biotherapeutics for $300 million

August 3, 2015
Shire has acquired privately held Foresight Biotherapeutics for a cash payment of $300 million, according to a press release.The acquisition includes the global rights…
Blog

BLOG: Patient financing also can be used as a marketing tool

August 3, 2015
I speak with health care practices on a regular basis. During these conversations, physicians usually ask a range of questions to help determine whether they should…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Gaining Insight to Optimize Patient Outcomes: What Can We Do to Improve Postoperative Inflammation and Pain?

Gaining Insight to Optimize Patient Outcomes: What Can We Do to Improve Postoperative Inflammation and Pain?

This activity is supported by an educational grant from Bausch + Lomb.

Postoperative pain and inflammation can result as a consequence of cataract surgery despite advances in surgical…
More »
Meeting News Coverage Video
VIDEO: Defining and treating astigmatism

VIDEO: Defining and treating astigmatism

July 26, 2015
At the Kiawah Eye 2015 meeting, John A. Hovanesian, MD, FACS, discusses how treating astigmatism in patients will…
More »
morganatic-roan